Clinical Trial: A Survey of Medical - Dental Collaboration for Management of Oral Mucositis Caused by Anticancer Drug Therapy (Japan)

Tokyo, Aug. 28 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058913) titled 'A Survey of Medical - Dental Collaboration for Management of Oral Mucositis Caused by Anticancer Drug Therapy' on Aug. 27.

Study Type: Observational

Primary Sponsor: Institute - Daiichi Sankyo Co., Ltd.

Condition: Condition - Oral mucositis caused by anticancer drug therapy Classification by malignancy - Malignancy Genomic information - NO

Objective: Narrative objectives1 - A web questionnaire survey will be conducted among Japanese physicians involved in cancer care, dentists, and oral surgeons to clarify the actual situation of oral mucositis management and medical-dental collaboration due to anticancer drug treatment. Basic objectives2 - Others

Eligibility: Age-lower limit - Not applicable Age-upper limit - Not applicable Gender - Male and Female Key inclusion criteria - Participants must meet all of the following eligibility criteria. [Physicians involved in cancer care] ･At least 5 years of clinical experience (including residency) ･Working at a facility with more than 100 inpatient beds ･Primary specialty in one of the following: -Gastrointestinal Surgery -Gastrointestinal Medicine -Thoracic Surgery -Pulmonary Medicine -Otorhinolaryngology -Breast Surgery -Obstetrics and Gynecology -Urology -Hematology -Medical Oncology ･Has administered anticancer agents to at least 20 patients in the past 12 months ･Examined at least one patient per month for oral mucositis caused by anticancer therapy ･Able to provide electronic informed consent of their own free will [Dentists / Oral Surgeons] ･At least 5 years of clinical experience (including residency) ･Primary specialty in Dentistry or Oral Surgery ･Has examined patients with oral mucositis caused by anticancer therapy ･Able to provide electronic informed consent of their own free will Key exclusion criteria - No setting in this study Target Size - 600

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2025 Year 05 Month 30 Day Date of IRB - 2025 Year 06 Month 18 Day Anticipated trial start date - 2025 Year 09 Month 16 Day Last follow-up date - 2025 Year 09 Month 26 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067376

Disclaimer: Curated by HT Syndication.